The Global Health Body Raises Alert Over Severe Lack of Obesity Injections
Less than 10% of individuals eligible to benefit from GLP-1 drugs like Wegovy have access to them, warns the global health agency as it releases its inaugural guidance on the therapies.
Considering in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is calling for more widespread and fairer availability to these injectable treatments.
According to estimates, more than two billion could be obese by 2030 without intervention.
"Our latest guidelines recognises that excess weight is a chronic disease that can be treated with comprehensive and continuous treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and supply-chain constraints are major barriers to universal access to the injections that can assist patients in reducing considerable weight, explains the organization.
Skinny Jab Scarcity
Even in the present most optimistic outlook, the supply of these medications would only suffice for around 100 million people – fewer than 10% of the global need, as stated by the WHO.
The recommendation calls on nations and manufacturers to expand access, via strategies such as patent sharing.
Exclusive production rights on the active ingredient – the main ingredient of the drug Wegovy – is set to lapse in several countries in 2026.
The Way Obesity Jabs Function
These medications imitate a biological compound to slow digestion, reduce hunger and enhance satiety so users eat less.
People typically start to lose weight within a few weeks of commencing the regular doses.
Evidence indicates people may regain a significant portion a year later of discontinuing the medication, as their typical food cravings come back.
Being above a healthy weight raises your chance for developing medical conditions, like type 2 diabetes, heart disease, stroke, and some cancers.
Obesity impacts individuals in every country and was associated with millions of fatalities worldwide in 2024, according to the health agency.